Imricor Medical Systems, Inc. (IMR.AX)
AUD 0.96
(-2.05%)
AUD 0.96
(-2.05%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 12.43 Million AUD | 243.3% |
| 2022 | 3.62 Million USD | 197.2% |
| 2021 | 1.21 Million AUD | 2.62% |
| 2020 | 1.18 Million AUD | 4118.46% |
| 2019 | 28.16 Thousand AUD | -97.94% |
| 2018 | 1.37 Million AUD | -53.91% |
| 2017 | 2.97 Million AUD | 32.05% |
| 2016 | 2.25 Million AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 7.8 Million USD | 0.0% |
| 2024 Q1 | 7.8 Million USD | -9.37% |
| 2023 Q1 | 5.65 Million USD | 56.21% |
| 2023 FY | 12.43 Million AUD | 243.3% |
| 2023 Q3 | 9.62 Million USD | 70.05% |
| 2023 Q2 | 5.65 Million USD | 0.0% |
| 2023 Q4 | 9.75 Million USD | 1.35% |
| 2022 Q4 | 3.62 Million USD | 1.23% |
| 2022 FY | 3.62 Million USD | 197.2% |
| 2022 Q3 | 3.57 Million USD | 126.13% |
| 2022 Q1 | 1.58 Million USD | 29.83% |
| 2022 Q2 | 1.58 Million USD | 0.0% |
| 2021 Q3 | 1.21 Million USD | 12.61% |
| 2021 FY | 1.21 Million AUD | 2.62% |
| 2021 Q1 | 1.08 Million USD | -29.82% |
| 2021 Q4 | 1.21 Million AUD | 0.0% |
| 2021 Q2 | 1.08 Million USD | 0.0% |
| 2020 Q4 | 1.54 Million AUD | -16.04% |
| 2020 FY | 1.18 Million AUD | 4118.46% |
| 2020 Q1 | 2.18 Million USD | 48.37% |
| 2020 Q2 | 2.18 Million USD | 0.0% |
| 2020 Q3 | 1.83 Million USD | -15.83% |
| 2019 Q4 | 1.47 Million USD | 0.0% |
| 2019 FY | 28.16 Thousand AUD | -97.94% |
| 2019 Q3 | 1.47 Million USD | -88.78% |
| 2019 Q2 | 13.1 Million USD | 0.0% |
| 2019 Q1 | 13.1 Million USD | 36.59% |
| 2018 FY | 1.37 Million AUD | -53.91% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | 9.59 Million USD | 0.0% |
| 2018 Q4 | 9.59 Million USD | 0.0% |
| 2017 FY | 2.97 Million AUD | 32.05% |
| 2016 FY | 2.25 Million AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| 4DMedical Limited | 4.17 Million AUD | -197.824% |
| Adherium Limited | - AUD | -Infinity% |
| Aroa Biosurgery Limited | 5.89 Million AUD | -110.819% |
| Atomo Diagnostics Limited | - AUD | -Infinity% |
| Anteris Technologies Ltd | 1.52 Million AUD | -713.3% |
| Control Bionics Limited | 336.16 Thousand AUD | -3599.73% |
| CardieX Limited | - AUD | -Infinity% |
| Compumedics Limited | - AUD | -Infinity% |
| Cochlear Limited | 202.1 Million AUD | 93.846% |
| CleanSpace Holdings Limited | 2.76 Million AUD | -349.562% |
| Cyclopharm Limited | 4.01 Million AUD | -209.936% |
| EMVision Medical Devices Ltd | 1.76 Million AUD | -604.083% |
| Nova Eye Medical Limited | - AUD | -Infinity% |
| HeraMED Limited | - AUD | -Infinity% |
| ImpediMed Limited | 810 Thousand AUD | -1435.457% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.74 Million AUD | -613.551% |
| Micro-X Limited | 65 Thousand AUD | -19034.151% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | - AUD | -Infinity% |
| PolyNovo Limited | 742 Thousand AUD | -1576.172% |
| Respiri Limited | - AUD | -Infinity% |
| SomnoMed Limited | 709.07 Thousand AUD | -1654.006% |
| Universal Biosensors, Inc. | 3.22 Million AUD | -285.567% |
| Uscom Limited | - AUD | -Infinity% |
| Visioneering Technologies, Inc. | - AUD | -Infinity% |